The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer-Reference-Cited by-同舟云学术

The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer

Published:2007-07-05 Issue:1 Volume:56 Page:61-65
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Seshadri Ram,Horsfall David J.,Firgaira Frank,McCaul Kieran,Setlur Vittal,Chalmers Anthony H.,Yeo Robyn,Ingram D.,Dawkins Hugh,Hahnel Roland,South Australian Breast Cancer Stud

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference20 articles.

1. Quality control of cathepsin-D measurement by the EORTC receptor study group;Benraad;Europ. J. Cancer,1992

2. Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int -2 oncogene amplification and node invasiveness;Brouillet;Europ. J. Cancer,1990

3. Why do so many prognostic markers fail to pan out?;Hilsenbeck;Breast Cancer Res. Treat.,1992

4. Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer;Horsfall;Brit. J. Cancer,1986

5. The role of cathepsin D in the invasiveness of human breast cancer cells;Johnson;Cancer Res.,1993

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer;Frontiers in Oncology;2021-02-01

2. HER2/neu over-expression predicts poor outcome in early gastric cancer without lymph node metastasis;Clinics and Research in Hepatology and Gastroenterology;2015-02

3. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients;BMC Cancer;2014-11-07

4. The progress of targeted therapy in advanced gastric cancer;Biomarker Research;2013-12

5. HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: A prospective cohort observation;International Journal of Cancer;2013-11-08